Compare SON & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SON | LNTH |
|---|---|---|
| Founded | 1899 | 1956 |
| Country | United States | United States |
| Employees | 22000 | N/A |
| Industry | Containers/Packaging | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.6B |
| IPO Year | 2014 | 2014 |
| Metric | SON | LNTH |
|---|---|---|
| Price | $47.84 | $96.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $60.13 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 1.6M | 890.2K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | ★ 510.30 | N/A |
| EPS | 0.68 | ★ 1.80 |
| Revenue | ★ $7,518,753,000.00 | $343,374,000.00 |
| Revenue This Year | $0.10 | N/A |
| Revenue Next Year | $1.82 | $14.19 |
| P/E Ratio | $70.37 | ★ $53.43 |
| Revenue Growth | ★ 41.72 | 3.62 |
| 52 Week Low | $38.65 | $47.27 |
| 52 Week High | $58.44 | $98.27 |
| Indicator | SON | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 39.65 | 69.50 |
| Support Level | $46.73 | $49.21 |
| Resistance Level | $49.16 | $98.27 |
| Average True Range (ATR) | 1.28 | 3.22 |
| MACD | -0.30 | 0.21 |
| Stochastic Oscillator | 28.60 | 86.67 |
Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.